Flatiron Health

Foundation Medicine and Flatiron Health Announce First-of-its-Kind Integration of Genomic Profiling Into OncoEMR®

Retrieved on: 
Tuesday, June 29, 2021

Oncology practices will now be able to order and track Foundation Medicine, Inc. s comprehensive genomic profiling (CGP) tests for their patients without leaving Flatiron Health s OncoEMR platform, the two companies announced today.

Key Points: 
  • Oncology practices will now be able to order and track Foundation Medicine, Inc. s comprehensive genomic profiling (CGP) tests for their patients without leaving Flatiron Health s OncoEMR platform, the two companies announced today.
  • Clinicians increasingly rely on genomic insights to guide clinical decision-making, and Foundation Medicine is committed to implementing new solutions that enable widespread access to CGP, said Kathleen Kaa, Interim Chief Commercial Officer at Foundation Medicine.
  • The integration of Foundation Medicine tests into OncoEMR, and other leading EMR systems to follow, is just one way were improving our offerings to fuel precision medicine for cancer patients.
  • "We are excited to welcome Foundation Medicine in the first of our planned CGP integrations with OncoEMR, said James Hamrick, MD, MPH, Vice President, Clinical Oncology at Flatiron Health.

NICE Partners with Flatiron Health to Develop Real-World Evidence Research Methodologies

Retrieved on: 
Tuesday, July 14, 2020

The National Institute for Health and Care Excellence (NICE, www.nice.org.uk ) is partnering with Flatiron Health ( www.flatiron.com ), an oncology research and technology company, to explore how real-world evidence (RWE) can inform the clinical and cost effectiveness of health technologies.

Key Points: 
  • The National Institute for Health and Care Excellence (NICE, www.nice.org.uk ) is partnering with Flatiron Health ( www.flatiron.com ), an oncology research and technology company, to explore how real-world evidence (RWE) can inform the clinical and cost effectiveness of health technologies.
  • Flatiron Health and NICE experts will together conduct research that leverages Flatiron expertise and evidence generated from Flatirons electronic health record (EHR)-derived database; no individual patient data will be shared.
  • NICE provides guidance and standards about health technologies and clinical practices to Englands National Health Service, and is a world leader in the development of evidence-based guidelines to improve health and social care.
  • Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care.

The American Cancer Society and Flatiron Health Announce Recipients of the Real-World Data Impact Award

Retrieved on: 
Wednesday, July 1, 2020

Three American Cancer Society researchers will receive the Real-World Data Impact Award to advance patient-centric research, the ACS and Flatiron Health announced today.

Key Points: 
  • Three American Cancer Society researchers will receive the Real-World Data Impact Award to advance patient-centric research, the ACS and Flatiron Health announced today.
  • The joint grant-making program supports both organizations goals of accelerating cancer research and improving treatment and outcomes for patients.
  • The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer.
  • Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care.

American Cancer Society & Flatiron Health Launch Real-World Data Impact Award

Retrieved on: 
Wednesday, December 4, 2019

The American Cancer Society (ACS) and Flatiron Health today announced the launch of the American Cancer Society & Flatiron Health Real-World Data Impact Award.

Key Points: 
  • The American Cancer Society (ACS) and Flatiron Health today announced the launch of the American Cancer Society & Flatiron Health Real-World Data Impact Award.
  • This joint grant-making program supports both organizations goals of accelerating cancer research and improving treatment and care options for patients.
  • The American Cancer Society is a global grassroots force of 1.5 million volunteers dedicated to saving lives, celebrating lives, and leading the fight for a world without cancer.
  • Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care.

Flatiron Health Announces Clinical Decision Support Application Through Epic’s App Orchard

Retrieved on: 
Wednesday, October 16, 2019

Flatiron Health , a healthcare technology company focused on accelerating cancer research and improving patient care, announces the availability of its clinical decision support and pathways application, Flatiron Assist, in the App Orchard .

Key Points: 
  • Flatiron Health , a healthcare technology company focused on accelerating cancer research and improving patient care, announces the availability of its clinical decision support and pathways application, Flatiron Assist, in the App Orchard .
  • Flatiron Assist supports oncologists in selecting therapies in line with best clinical practices, including the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines), and in identifying potentially relevant clinical trials.
  • Available now in the App Orchard, Flatiron Assist is a SMART on FHIR application that will launch from the patients chart in Epic, eliminating the need for duplicate data entry outside the electronic medical record.
  • Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care.

West Cancer Center Implements Flatiron Revenue Cycle Management

Retrieved on: 
Wednesday, June 26, 2019

Flatiron Health announced today that West Cancer Center and Research Institute fully implemented their Flatiron Revenue Cycle Management service to optimize their financial performance.

Key Points: 
  • Flatiron Health announced today that West Cancer Center and Research Institute fully implemented their Flatiron Revenue Cycle Management service to optimize their financial performance.
  • Based in Memphis, Tennessee and a founding practice of OneOncology , West Cancer Center is a world-class comprehensive cancer center and leader in cancer research.
  • Our partnership with Flatiron Revenue Cycle Management accelerates our organizational goals, optimizes our financial outcomes and enables our teams to focus where they are needed most our patients, said Carol Carnell, MBA, BSN, Chief Administrative Officer, West Cancer Center.
  • We are thrilled to partner with West Cancer Clinic through our Revenue Cycle Management offering, said Gail Airasian, Vice President of Sales and Services at Flatiron.